ANZTCT 实践声明:窦性阻塞综合征/静脉闭塞症的诊断和管理。

IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Internal Medicine Journal Pub Date : 2024-07-30 DOI:10.1111/imj.16453
Shaun Fleming, Ashleigh P. Scott, John Coutsouvelis, Chris Fraser, Ashish Bajel, Adam Nelson, Rachel Conyers, Ashley McEwan, David Yeung, Victoria Campion, Lochie Teague, Matthew McGuire, Edward Morris, Melissa Gabriel, Rebecca Wayte, Genevieve Douglas, Nicole Chien, Nada Hamad
{"title":"ANZTCT 实践声明:窦性阻塞综合征/静脉闭塞症的诊断和管理。","authors":"Shaun Fleming,&nbsp;Ashleigh P. Scott,&nbsp;John Coutsouvelis,&nbsp;Chris Fraser,&nbsp;Ashish Bajel,&nbsp;Adam Nelson,&nbsp;Rachel Conyers,&nbsp;Ashley McEwan,&nbsp;David Yeung,&nbsp;Victoria Campion,&nbsp;Lochie Teague,&nbsp;Matthew McGuire,&nbsp;Edward Morris,&nbsp;Melissa Gabriel,&nbsp;Rebecca Wayte,&nbsp;Genevieve Douglas,&nbsp;Nicole Chien,&nbsp;Nada Hamad","doi":"10.1111/imj.16453","DOIUrl":null,"url":null,"abstract":"<p>Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a life-threatening complication which can develop after haemopoietic stem cell transplantation (HSCT) and some antibody–drug conjugates. Several SOS/VOD diagnostic and management guidelines exist, with the most recent and refined being the European Society for Blood and Marrow Transplantation adult and paediatric guidelines. Timely diagnosis and effective management (including the availability of therapeutic options) significantly contribute to improved patient outcomes. In Australia and New Zealand, there is variability in clinical practice and access to SOS/VOD therapies. This review aims to summarise the current evidence for SOS/VOD diagnosis, prevention and treatment and to provide recommendations for SOS/VOD in the context of contemporary Australasian HSCT clinical practice.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 9","pages":"1548-1556"},"PeriodicalIF":1.8000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16453","citationCount":"0","resultStr":"{\"title\":\"ANZTCT practice statement: sinusoidal obstruction syndrome/veno-occlusive disease diagnosis and management\",\"authors\":\"Shaun Fleming,&nbsp;Ashleigh P. Scott,&nbsp;John Coutsouvelis,&nbsp;Chris Fraser,&nbsp;Ashish Bajel,&nbsp;Adam Nelson,&nbsp;Rachel Conyers,&nbsp;Ashley McEwan,&nbsp;David Yeung,&nbsp;Victoria Campion,&nbsp;Lochie Teague,&nbsp;Matthew McGuire,&nbsp;Edward Morris,&nbsp;Melissa Gabriel,&nbsp;Rebecca Wayte,&nbsp;Genevieve Douglas,&nbsp;Nicole Chien,&nbsp;Nada Hamad\",\"doi\":\"10.1111/imj.16453\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a life-threatening complication which can develop after haemopoietic stem cell transplantation (HSCT) and some antibody–drug conjugates. Several SOS/VOD diagnostic and management guidelines exist, with the most recent and refined being the European Society for Blood and Marrow Transplantation adult and paediatric guidelines. Timely diagnosis and effective management (including the availability of therapeutic options) significantly contribute to improved patient outcomes. In Australia and New Zealand, there is variability in clinical practice and access to SOS/VOD therapies. This review aims to summarise the current evidence for SOS/VOD diagnosis, prevention and treatment and to provide recommendations for SOS/VOD in the context of contemporary Australasian HSCT clinical practice.</p>\",\"PeriodicalId\":13625,\"journal\":{\"name\":\"Internal Medicine Journal\",\"volume\":\"54 9\",\"pages\":\"1548-1556\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.16453\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Internal Medicine Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/imj.16453\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Internal Medicine Journal","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imj.16453","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

窦性阻塞综合征/静脉闭塞性疾病(SOS/VOD)是造血干细胞移植(HSCT)和某些抗体药物共轭物治疗后可能出现的一种危及生命的并发症。目前已有多份 SOS/VOD 诊断和管理指南,其中最新和最完善的是欧洲血液与骨髓移植学会成人和儿科指南。及时诊断和有效管理(包括提供治疗方案)大大有助于改善患者的预后。在澳大利亚和新西兰,SOS/VOD疗法的临床实践和使用情况存在差异。本综述旨在总结有关 SOS/VOD 诊断、预防和治疗的现有证据,并结合当代澳大利亚造血干细胞移植临床实践为 SOS/VOD 提供建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
ANZTCT practice statement: sinusoidal obstruction syndrome/veno-occlusive disease diagnosis and management

Sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) is a life-threatening complication which can develop after haemopoietic stem cell transplantation (HSCT) and some antibody–drug conjugates. Several SOS/VOD diagnostic and management guidelines exist, with the most recent and refined being the European Society for Blood and Marrow Transplantation adult and paediatric guidelines. Timely diagnosis and effective management (including the availability of therapeutic options) significantly contribute to improved patient outcomes. In Australia and New Zealand, there is variability in clinical practice and access to SOS/VOD therapies. This review aims to summarise the current evidence for SOS/VOD diagnosis, prevention and treatment and to provide recommendations for SOS/VOD in the context of contemporary Australasian HSCT clinical practice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Internal Medicine Journal
Internal Medicine Journal 医学-医学:内科
CiteScore
3.50
自引率
4.80%
发文量
600
审稿时长
3-6 weeks
期刊介绍: The Internal Medicine Journal is the official journal of the Adult Medicine Division of The Royal Australasian College of Physicians (RACP). Its purpose is to publish high-quality internationally competitive peer-reviewed original medical research, both laboratory and clinical, relating to the study and research of human disease. Papers will be considered from all areas of medical practice and science. The Journal also has a major role in continuing medical education and publishes review articles relevant to physician education.
期刊最新文献
Final results of the National Oncology Mentorship Program 2023 and its impact on burnout and professional fulfilment. Platelet factor 4 immune disease: medical emergencies that look like heparin-induced thrombocytopenia. Correction to: 'Managing cancer-related pain in the setting of proven IgE-mediated opioid anaphylaxis'. Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer. Environmental impact of large language models in medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1